Literature DB >> 12094383

Detection of molecular cytogenetic aberrations in langerhans cell histiocytosis of bone.

Ichiro Murakami1, Jean Gogusev, Jean Christophe Fournet, Christophe Glorion, Francis Jaubert.   

Abstract

Langerhans cell histiocytosis (LCH) is a disorder of unknown etiology that gives rise to clonal expansion of Langerhans-like cells or their precursors. The molecular basis include aberrant expression of several adhesion molecules and elevated expression of p53, c-myc, and H-ras. To identify new locations of LCH-related oncogenes or tumor-suppressor genes, we performed comparative genomic hybridization (CGH) and loss of heterozygosity (LOH) analysis on a series of 7 bone LCH lesions. Recurrent abnormalities were found by the CGH in all cases representing losses of DNA sequences on chromosomes 1p, 5, 6, 7, 9, 16, 17, and 22q. Gain of DNA copy number was seen on chromosomes 2q, 4q, and 12. The CGH data were supplemented by LOH analysis by means of 85 polymorphic microsatellite markers distributed along chromosomes 1, 7, 9, and 22. The highest frequency of LOH was found on 1p region in 3 of 7 informative cases and on chromosome 7 in 4 cases. Allelic loss was also detected on chromosomes 9 in 2 of 7 informative cases and on 22q in 1 of 7 cases. These results indicate that the deleted chromosomal segments may contain genes important in LCH initiation and progression. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12094383     DOI: 10.1053/hupa.2002.124035

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

1.  Eosinophilic granuloma of mandibular condyle: resection and complete regeneration.

Authors:  Varghese Mani; V Sankar Vinod; Arun George; K K Sivaprasad
Journal:  J Maxillofac Oral Surg       Date:  2013-09-13

2.  Langerhans cell histiocytosis: malignancy or inflammatory disorder doing a great job of imitating one?

Authors:  Barbara A Degar; Barrett J Rollins
Journal:  Dis Model Mech       Date:  2009 Sep-Oct       Impact factor: 5.758

Review 3.  Selected Giant Cell Rich Lesions of the Temporal Bone.

Authors:  Anthony P Martinez; Jorge Torres-Mora
Journal:  Head Neck Pathol       Date:  2018-08-01

4.  IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy.

Authors:  Ichiro Murakami; Akira Morimoto; Takashi Oka; Satoshi Kuwamoto; Masako Kato; Yasushi Horie; Kazuhiko Hayashi; Jean Gogusev; Francis Jaubert; Shinsaku Imashuku; Lamia Abd Al-Kadar; Katsuyoshi Takata; Tadashi Yoshino
Journal:  Virchows Arch       Date:  2012-12-27       Impact factor: 4.064

5.  New insights into the molecular pathogenesis of langerhans cell histiocytosis.

Authors:  Francesca M Rizzo; Mauro Cives; Valeria Simone; Franco Silvestris
Journal:  Oncologist       Date:  2014-01-16

6.  Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior.

Authors:  Benoit Hedan; Rachael Thomas; Alison Motsinger-Reif; Jerome Abadie; Catherine Andre; John Cullen; Matthew Breen
Journal:  BMC Cancer       Date:  2011-05-26       Impact factor: 4.430

Review 7.  Merkel cell polyomavirus and Langerhans cell neoplasm.

Authors:  Ichiro Murakami; Noriko Wada; Junko Nakashima; Mitsuko Iguchi; Makoto Toi; Yumiko Hashida; Tomonori Higuchi; Masanori Daibata; Michiko Matsushita; Takeshi Iwasaki; Satoshi Kuwamoto; Yasushi Horie; Keiko Nagata; Kazuhiko Hayashi; Takashi Oka; Tadashi Yoshino; Toshihiko Imamura; Akira Morimoto; Shinsaku Imashuku; Jean Gogusev; Francis Jaubert
Journal:  Cell Commun Signal       Date:  2018-08-22       Impact factor: 5.712

8.  Expansion of regulatory T cells in patients with Langerhans cell histiocytosis.

Authors:  Brigitte Senechal; Gaelle Elain; Eric Jeziorski; Virginie Grondin; Natacha Patey-Mariaud de Serre; Francis Jaubert; Kheira Beldjord; Arielle Lellouch; Christophe Glorion; Michel Zerah; Pierre Mary; Mohammed Barkaoui; Jean Francois Emile; Liliane Boccon-Gibod; Patrice Josset; Marianne Debré; Alain Fischer; Jean Donadieu; Frederic Geissmann
Journal:  PLoS Med       Date:  2007-08       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.